Topic Hub
13 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 13 of 13 clinical reviews.
Specific dietary, meal-timing, hydration, and lifestyle strategies with clinical evidence for reducing progesterone-induced sedation from allopregnanolone GABA-A activity.
Read clinical reviewEvidence-based dietary strategies to reduce sedation from oral micronized progesterone (Prometrium). Covers timing with meals, fat content, magnesium, B6, and GABA-modulating nutrients.
Read clinical reviewA clinical deep-dive into OTC and prescription options for managing progesterone-induced sedation, including dose ranges, timing strategies, drug interactions to avoid, and when to escalate or switch formulations.
Read clinical reviewLearn why oral micronized progesterone causes sedation through its allopregnanolone metabolite, how to manage drowsiness, and when sedation signals a need for medical attention.
Read clinical reviewWhy sedation from oral micronized progesterone persists in some patients, what drives it biochemically, and evidence-based strategies to manage or eliminate it.
Read clinical reviewWhy oral micronized progesterone causes sedation through its allopregnanolone metabolite, how to manage drowsiness, and which progesterone formulations avoid GABA-A receptor activity.
Read clinical reviewA clinical severity grading rubric for sedation caused by oral micronized progesterone (Prometrium), including mechanism, management strategies, and when to adjust therapy.
Read clinical reviewHow common is sedation on oral micronized progesterone, how severe does it get, who is most at risk, and what does the evidence say about how it resolves? A clinically detailed overview for patients and prescribers.
Read clinical reviewA week-by-week clinical breakdown of progesterone-related sedation: when it starts, when it peaks, when it resolves, and what the trial data show. Includes dosing strategies, red flags, and patient FAQs.
Read clinical reviewA clinical deep-dive into how slowing titration, pausing doses, stepping down, and microdosing can resolve progesterone-induced sedation. Includes real protocols, timelines, and when each strategy fails.
Read clinical reviewPrecise clinical criteria for when sedation from oral micronized progesterone crosses the threshold for discontinuation, including severity grading, quality-of-life benchmarks, alternative regimens, and what the trial evidence actually says.
Read clinical reviewOral micronized progesterone causes sedation because the liver converts it to allopregnanolone, a potent GABA-A receptor modulator. Learn the neurobiology, dose-response data, and management strategies.
Read clinical reviewA clinical deep-dive into why oral micronized progesterone causes sedation, covering the allopregnanolone-GABA-A receptor mechanism, dose-response data, and practical strategies to manage drowsiness while staying on therapy.
Read clinical review